Human milk processing company LactaLogics recently held its first onsite Clinical and Scientific Advisory Board (CSAB) meeting in Port St. Lucie, Florida. The meeting was attended by their clinical and scientific board and advisors, composed of top physicians, nurses, and research scientists in the fields of neonatology, food science, and lactation.
“Although we fully explored Gentle-UHT and how it’s broadening the horizons of human milk-based processing, it was most exciting to hear from our clinician partners how this technology will change the status quo for infant nutrition.”
Chelly Snow, co-founder and COO, LactaLogics
Focusing on the importance of nutrition for the healthy growth and development of premature and at-risk infants, attendees discussed increasing complexities in neonatal cases, the role expanded human milk access will play, and the emerging processing technology, Gentle-UHT.
The event included presentations at Hutchinson Shores Resort & Spa and LactaLogics’ new headquarters and processing facility, both located within Florida’s Treasure Coast.
“As a human milk processing company, we play only one part in providing access to an exclusive human milk diet. It’s a shared responsibility with donor moms, who provide their excess milk, and clinicians, who manage the complexities of nutrition in neonatal care,” shared Glenn Snow, co-founder and CEO. “The way our CSAB and advisors welcomed this responsibility made the meeting a resounding success, getting us one step closer to babies having access to what they need to thrive.”
“Although we fully explored Gentle-UHT and how it’s broadening the horizons of human milk-based processing, it was most exciting to hear from our clinician partners how this technology will change the status quo for infant nutrition,” added Chelly Snow, co-founder and COO.
As LactaLogics continues to move forward in accomplishing their mission to bring more human milk to babies, it is committed to continuing its collaboration with its CSAB, advisors, and other leading clinicians to drive innovation and bring more human milk to infants.
